DEC 15, 2018 11:57 PM PST

Ebola-Fighting Protein Paves The Way For New Drugs

WRITTEN BY: Nouran Amin

In a study published in Cell, research at Northwestern University School of Medicine has involved scientists discovering a human protein that could be the key to eradicating the Ebola virus—opening the doors to possible drug therapies. The discovered protein is called RBBP6 and works by interfering with the Ebola virus replication inhibiting its survival.

 

 

"One of the scariest parts about the 2014 Ebola outbreak was that we had no treatments on hand; tens of thousands of people became sick and thousands of people died because we lacked a suitable treatment," Hultquist said. "What we envision is a small molecule drug that mimics this human protein and could be used in response to an Ebola virus outbreak."

Viruses develop proteins that evolve to develop even more advanced proteins that bypass the body’s immune defense system. Interestingly, human cells in turn also evolve new defense mechanisms against those viruses producing an evolutionary arms race with a therapeutic potential.

"It wasn't until the outbreak of 2014 that other countries started seriously worrying about the potential for a larger epidemic," Hultquist said. "It's no longer going to be a local problem that people can afford to ignore. We should be taking a much more proactive stance against some of these neglected viruses and be studying them in real time -- so the next time an outbreak does occur, we're ready for it."

Ebola-fighting protein discovered in human cells.

Credit: Northwestern University

The research study is hoping to gear towards the development of a small drug molecule that is able to enter human cells more easily for treatment. Their studies using structural and computational analysis has narrowed their research to a small peptide consisting of 23 amino acids. The small peptide chain was found to be efficient enough to disrupt the Ebola virus.

"If you take that peptide and put it into human cells, you can block Ebola virus infection," Hultquist said. "Conversely, when you remove the RBBP6 protein from human cells, Ebola virus replicates much faster."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
New Painkiller More Effective than Opioids Discovered in Mud
Researchers have discovered a new painkiller dubbed to be as effective as opioids, only minus their disadvantages, from a 16-year old mud sample found near...
DEC 06, 2019
Microbiology
DEC 06, 2019
Hybrid Antibiotic Can Destroy Dangerous Staph Biofilms
When staph begins to grow on medical devices like implants used on wounds, artificial joints, or catheters, they can cause chronic, serious infections....
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
A New Drug Target for Substance Abuse
Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the dru...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
Treating stroke with low dose of clot-busting drug
A study concludes that a low-dose of the clot-busting drug—tenecteplase—may be beneficial for eligible stroke patients that do not need an inte...
Loading Comments...